CHEK2 and breast carcinoma: BRCA1 and BRCA2’s PVs were associated with breast cancer, ovarian/fallopian cancer, pancreas cancer, prostate cancer, and melanoma, while breast, prostate, thyroid, kidney, colon and stomach cancers were related to PVs in CHEK2 [23].